Grzegorz S Nowakowski, MD

  • 4778 Citations
  • 42 Scopus h-Index
20012020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 4778 Citations
  • 42 Scopus h-Index
  • 115 Article
  • 14 Review article
  • 13 Letter
  • 3 Comment/debate
2020

Clinicopathological features, treatment approaches, and outcomes in Rosai-Dorfman disease

Goyal, G., Ravindran, A., Young, J. R., Shah, M. V., Bennani, N. N., Patnaik, M. M., Nowakowski, G. S., Thanarajasingam, G., Habermann, T. M., Vassallo, R., Sher, T., Parikh, S. A., Rech, K. L. & Go, R. S., Jan 31 2020, In : Haematologica. 105, 2, p. 348-357 10 p.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

ENGINE: A Phase III randomized placebo controlled study of enzastaurin/R-CHOP as frontline therapy in high-risk diffuse large B-cell lymphoma patients with the genomic biomarker DGM1

Nowakowski, G. S., Zhu, J., Zhang, Q., Brody, J., Sun, X., Maly, J., Song, Y., Rizvi, S., Song, Y., Lansigan, F., Jing, H., Cao, J., Lue, J. K., Luo, W., Zhang, L., Li, L., Han, I., Sun, J., Jivani, M., Liu, Y. & 2 others, Heineman, T. & Smith, S. D., May 2020, In : Future Oncology. 16, 15, p. 991-999 9 p.

Research output: Contribution to journalArticle

Open Access

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia

Zanwar, S., Abeykoon, J. P., Durot, E., King, R., Perez Burbano, G. E., Kumar, S., Gertz, M. A., Quinquenel, A., Delmer, A., Gonsalves, W., Cornillet-Lefebvre, P., He, R., Warsame, R., Buadi, F. K., Novak, A. J., Greipp, P. T., Inwards, D., Habermann, T. M., Micallef, I., Go, R. & 19 others, Muchtar, E., Kourelis, T., Dispenzieri, A., Lacy, M. Q., Dingli, D., Nowakowski, G., Thompson, C. A., Johnston, P., Thanarajasingam, G., Bennani, N. N., Witzig, T. E., Villasboas, J., Leung, N., Lin, Y., Kyle, R. A., Rajkumar, S. V., Ansell, S. M., Le-Rademacher, J. G. & Kapoor, P., Mar 1 2020, In : American journal of hematology. 95, 3, p. 274-281 8 p.

Research output: Contribution to journalArticle

3 Scopus citations

Leveraging gene expression subgroups to classify DLBCL patients and select for clinical benefit from a novel agent

Risueño, A., Hagner, P. R., Towfic, F., Fontanillo, C., Djebbari, A., Parker, J. S., Drew, C. P., Nowakowski, G. S., Maurer, M. J., Cerhan, J. R., Wei, X., Ren, Y., Lee, C. W., Couto, S., Wang, M., Pourdehnad, M., Gandhi, A. K. & Trotter, M. W. B., Mar 26 2020, In : Blood. 135, 13, p. 1008-1018 11 p.

Research output: Contribution to journalArticle

Persistent mediastinal FDG uptake on PET-CT after frontline therapy for Hodgkin lymphoma: biopsy, treat or observe?

Novo, M., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Micallef, I. N., Johnston, P. B., Inwards, D. J., Botto, B., Ristow, K. M., Young, J. R., Vitolo, U. & Ansell, S. M., Jan 28 2020, In : Leukemia and Lymphoma. 61, 2, p. 318-327 10 p.

Research output: Contribution to journalArticle

1 Scopus citations

Targetability of STAT3-JAK2 fusions: implications for T-cell lymphoproliferative disorders of the gastrointestinal tract

Hu, G., Phillips, J. L., Dasari, S., Jacobs, H. K., Luchtel, R. A., Oishi, N., Hundal, T., Ahmed, N. H., Satou, A., Epstein, A. L., Bennani, N. N., Nowakowski, G. S., Murray, J. A. & Feldman, A. L., May 1 2020, In : Leukemia. 34, 5, p. 1467-1471 5 p.

Research output: Contribution to journalArticle

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL

Hartert, K. T., Wenzl, K., Krull, J. E., Manske, M., Sarangi, V., Asmann, Y., Larson, M. C., Maurer, M. J., Slager, S., Macon, W. R., King, R. L., Feldman, A. L., Gandhi, A. K., Link, B. K., Habermann, T. M., Yang, Z. Z., Ansell, S. M., Cerhan, J. R., Witzig, T. E., Nowakowski, G. S. & 1 others, Novak, A. J., 2020, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma

Nowakowski, G. S., Chiappella, A., Witzig, T. E., Scott, D. W., Spina, M., Gascoyne, R. D., Zhang, L., Russo, J., Kang, J., Zhang, J., Xu, Y. & Vitolo, U., Jan 31 2020, In : Haematologica. 105, 2, p. E72-E75

Research output: Contribution to journalLetter

Open Access
1 Scopus citations
2019

Amplification of 9p24.1 in diffuse large B-cell lymphoma identifies a unique subset of cases that resemble primary mediastinal large B-cell lymphoma

Wang, Y., Wenzl, K., Manske, M. K., Asmann, Y., Sarangi, V., Greipp, P. T., Krull, J. E., Hartert, K., He, R., Feldman, A. L., Maurer, M. J., Slager, S. L., Nowakowski, G. S., Habermann, T. M., Witzig, T. E., Link, B. K., Ansell, S. M., Cerhan, J. R. & Novak, A. J., Sep 1 2019, In : Blood cancer journal. 9, 9, 73.

Research output: Contribution to journalArticle

Open Access
3 Scopus citations

AUGMENT: A Phase III study of lenalidomide plus rituximab versus placebo plus rituximab in relapsed or refractory indolent lymphoma

Leonard, J. P., Trneny, M., Izutsu, K., Fowler, N. H., Hong, X., Zhu, J., Zhang, H., Offner, F., Scheliga, A., Nowakowski, G. S., Pinto, A., Re, F., Fogliatto, L. M., Scheinberg, P., Flinn, I. W., Moreira, C., Cabeçadas, J., Liu, D., Kalambakas, S., Fustier, P. & 2 others, Wu, C. & Gribben, J. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 14, p. 1188-1199 12 p.

Research output: Contribution to journalArticle

Open Access
38 Scopus citations

Detection of extranodal and spleen involvement by FDG-PET imaging predicts adverse survival in untreated follicular lymphoma

St-Pierre, F., Broski, S. M., LaPlant, B. R., Ristow, K., Maurer, M. J., Macon, W. R., Habermann, T. M., Ansell, S. M., Thompson, C. A., Micallef, I. N. M., Nowakowski, G. S. & Witzig, T. E., Jul 2019, In : American journal of hematology. 94, 7, p. 786-793 8 p.

Research output: Contribution to journalArticle

5 Scopus citations

End-of-Treatment PET/Computed Tomography Response in Diffuse Large B-Cell Lymphoma

Kostakoglu, L. & Nowakowski, G. S., Jul 1 2019, In : PET Clinics. 14, 3, p. 307-315 9 p.

Research output: Contribution to journalReview article

1 Scopus citations

Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphoma

Wang, Y., Link, B. K., Witzig, T. E., Maurer, M. J., Allmer, C., King, R. L., Feldman, A. L., Habermann, T. M., Ansell, S. M., Slager, S. L., Cerhan, J. R. & Nowakowski, G. S., Oct 17 2019, In : Blood. 134, 16, p. 1289-1297 9 p.

Research output: Contribution to journalArticle

Open Access
4 Scopus citations
2 Scopus citations

Integrating precision medicine through evaluation of cell of origin in treatment planning for diffuse large B-cell lymphoma

Nowakowski, G. S., Feldman, T., Rimsza, L. M., Westin, J. R., Witzig, T. E. & Zinzani, P. L., Jun 1 2019, In : Blood cancer journal. 9, 6, 48.

Research output: Contribution to journalReview article

Open Access
4 Scopus citations

Late relapses in patients with diffuse large b-cell lymphoma treated with immunochemotherapy

Wang, Y., Farooq, U., Link, B. K., Larson, M. C., King, R., Maurer, M. J., Allmer, C., Hefazi, M., Thompson, C. A., Micallef, I., Johnston, P. B., Habermann, T. M., Witzig, T. E., Ansell, S. M., Cerhan, J. R. & Nowakowski, G. S., Jul 20 2019, In : Journal of Clinical Oncology. 37, 21, p. 1819-1827 9 p.

Research output: Contribution to journalArticle

6 Scopus citations

Pretreatment hemoglobin adds prognostic information to the nccn-ipi in patients with diffuse large b-cell lymphoma treated with anthracycline-containing chemotherapy

Clausen, M. R., Maurer, M. J., Ulrichsen, S. P., Larsen, T. S., Himmelstrup, B., Rønnov-Jessen, D., Link, B. K., Feldman, A. L., Slager, S. L., Nowakowski, G. S., Thompson, C. A., Pedersen, P. T., Madsen, J., Pedersen, R. S., Gørløv, J. S., Cerhan, J. R., Nørgaard, M. & D’amore, F., 2019, In : Clinical Epidemiology. 11, p. 987-996 10 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
6 Scopus citations

Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis

Wang, Y., Zhou, S., Yang, F., Qi, X., Wang, X., Guan, X., Shen, C., Duma, N., Vera Aguilera, J., Chintakuntlawar, A., Price, K. A., Molina, J. R., Pagliaro, L., Halfdanarson, T. R., Grothey, A., Markovic, S. N., Nowakowski, G. S., Ansell, S. M. & Wang, M. L., Jul 2019, In : JAMA Oncology. 5, 7, p. 1008-1019 12 p.

Research output: Contribution to journalReview article

78 Scopus citations
2018

A case of ibrutinib-associated aspergillosis presenting with central nervous system, myocardial, pulmonary, intramuscular, and subcutaneous abscesses

McCarter, S. J., Vijayvargiya, P., Sidana, S., Nault, A. M., Lane, C. E., Lehman, J., Wilson, J. W., Parikh, S. A., Nowakowski, G. S. & Al-Kali, A., Jan 1 2018, (Accepted/In press) In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

5 Scopus citations

Advances in CD30- and PD-1-targeted therapies for classical Hodgkin lymphoma

Wang, Y., Nowakowski, G. S., Wang, M. L. & Ansell, S. M., Apr 23 2018, In : Journal of Hematology and Oncology. 11, 1, 57.

Research output: Contribution to journalReview article

4 Scopus citations

A Novel Combination of the mTORC1 Inhibitor Everolimus and the Immunomodulatory Drug Lenalidomide Produces Durable Responses in Patients With Heavily Pretreated Relapsed Lymphoma

Padrnos, L., Ernst, B., Dueck, A. C., Kosiorek, H. E., Ginos, B. F., Toro, A., Johnston, P. B., Habermann, T. M., Leis, J. F., Mikhael, J. R., Nowakowski, G. S., Colgan, J., Porrata, L., Ansell, S. M., Witzig, T. E. & Reeder, C. B., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

1 Scopus citations

CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): Analysis from two phase 2 studies

Ayed, A. O., Chiappella, A., Pederson, L., Laplant, B. R., Congiu, A. G., Gaidano, G., Spina, M., Re, A., Cavallo, F., Musuraca, G., MacOn, W. R., Witzig, T., Vitolo, U. & Nowakowski, G. S., Jul 1 2018, In : Blood cancer journal. 8, 7, 63.

Research output: Contribution to journalArticle

6 Scopus citations

Diagnosis-to-treatment interval is an important clinical factor in newly diagnosed diffuse large B-cell lymphoma and has implication for bias in clinical trials

Maurer, M. J., Ghesquières, H., Link, B. K., Jais, J. P., Habermann, T. M., Thompson, C. A., Haioun, C., Allmer, C., Johnston, P. B., Delarue, R., Micallef, I. N., Peyrade, F., Inwards, D. J., Ketterer, N., Farooq, U., Fitoussi, O., Macon, W. R., Molina, T. J., Syrbu, S., Feldman, A. L. & 8 others, Slager, S. L., Weiner, G. J., Ansell, S. M., Cerhan, J. R., Salles, G. A., Witzig, T. E., Tilly, H. & Nowakowski, G. S., Jun 1 2018, In : Journal of Clinical Oncology. 36, 16, p. 1603-1610 8 p.

Research output: Contribution to journalArticle

30 Scopus citations
3 Scopus citations

High-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology

Scott, D. W., King, R. L., Staiger, A. M., Ben-Neriah, S., Jiang, A., Horn, H., Mottok, A., Farinha, P., Slack, G. W., Ennishi, D., Schmitz, N., Pfreundschuh, M., Nowakowski, G. S., Kahl, B. S., Connors, J. M., Gascoyne, R. D., Ott, G., Macon, W. R. & Rosenwald, A., May 3 2018, In : Blood. 131, 18, p. 2060-2064 5 p.

Research output: Contribution to journalArticle

44 Scopus citations

History of autoimmune conditions and lymphoma prognosis

Kleinstern, G., Maurer, M. J., Liebow, M., Habermann, T. M., Koff, J. L., Allmer, C., Witzig, T. E., Nowakowski, G. S., Micallef, I., Johnston, P. B., Inwards, D. J., Thompson, C. A., Feldman, A. L., Link, B. K., Flowers, C., Slager, S. L. & Cerhan, J. R., Aug 1 2018, In : Blood Cancer Journal. 8, 8, 73.

Research output: Contribution to journalArticle

4 Scopus citations

Human Pegivirus infection and lymphoma risk and prognosis: a North American study

Fama, A., Xiang, J., Link, B. K., Allmer, C., Klinzman, D., Feldman, A. L., Nowakowski, G. S., Liebow, M., Larson, M. C., Maurer, M. J., Ansell, S. M., Novak, A. J., Asmann, Y. W., Slager, S. L., Call, T. G., Habermann, T. M., Cerhan, J. R. & Stapleton, J. T., Sep 2018, In : British journal of haematology. 182, 5, p. 644-653 10 p.

Research output: Contribution to journalArticle

9 Scopus citations

Identification of Factors Associated with Hematology-Oncology Fellow Academic Success and Career Choice

Marshall, A. L., Gupta, R., Grill, D., Mann, S., Freidline, K., Nowakowski, G. S., Thompson, C. A. & Hobday, T. J., Jan 1 2018, (Accepted/In press) In : Journal of Cancer Education.

Research output: Contribution to journalArticle

1 Scopus citations

Inferior survival in high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements is not associated with MYC/IG gene rearrangements

McPhail, E. D., Maurer, M. J., Macon, W. R., Feldman, A. L., Kurtin, P. J., Ketterling, R. P., Vaidya, R., Cerhan, J. R., Ansell, S. M., Porrata, L. F., Nowakowski, G. S., Witzig, T. E. & Habermann, T. M., Oct 31 2018, In : Haematologica. 103, 11, p. 1899-1907 9 p.

Research output: Contribution to journalArticle

16 Scopus citations

Lenalidomide plus R-CHOP21 in newly diagnosed diffuse large B-cell lymphoma (DLBCL): long-term follow-up results from a combined analysis from two phase 2 trials

Castellino, A., Chiappella, A., LaPlant, B. R., Pederson, L. D., Gaidano, G., Macon, W. R., Inghirami, G., Reeder, C. B., Tucci, A., King, R. L., Congiu, A., Foran, J. M., Pavone, V., Rivera, C. E., Spina, M., Ansell, S. M., Cavallo, F., Molinari, A. L., Ciccone, G., Habermann, T. M. & 3 others, Witzig, T. E., Vitolo, U. & Nowakowski, G. S., Nov 1 2018, In : Blood cancer journal. 8, 11, 108.

Research output: Contribution to journalArticle

8 Scopus citations

Outcomes among North American patients with diffuse large b-cell lymphoma are independent of tumor Epstein-Barr virus positivity or immunosuppression

Tracy, S. I., Habermann, T. M., Feldman, A. L., Maurer, M. J., Dogan, A., Perepu, U. S., Syrbu, S., Ansell, S. M., Thompson, C. A., Weiner, G. J., Nowakowski, G. S., Allmer, C., Slager, S. L., Witzig, T. E., Cerhan, J. R. & Link, B. K., Jan 31 2018, In : Haematologica. 103, 2, p. 297-303 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

Primary systemic amyloidosis in patients with Waldenström macroglobulinemia

Zanwar, S., Abeykoon, J. P., Ansell, S. M., Gertz, M. A., Dispenzieri, A., Muchtar, E., Sidana, S., Tandon, N., Rajkumar, S. V., Dingli, D., Go, R. S., Lacy, M. Q., Kourelis, T., Witzig, T. E., Inwards, D., Buadi, F., Gonsalves, W., Habermann, T., Johnston, P., Nowakowski, G. & 3 others, Kyle, R. A., Kumar, S. & Kapoor, P., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

5 Scopus citations

Rapid, real time pathology review for ECOG/ACRIN 1412: A novel and successful paradigm for future lymphoma clinical trials in the precision medicine era

King, R. L., Nowakowski, G. S., Witzig, T. E., Scott, D. W., Little, R. F., Hong, F., Gascoyne, R. D., Kahl, B. S. & Macon, W. R., Mar 1 2018, In : Blood cancer journal. 8, 3, 27.

Research output: Contribution to journalReview article

4 Scopus citations

Recurrent stat3-jak2 fusions in indolent t-cell lymphoproliferative disorder of the gastrointestinal tract

Sharma, A., Oishi, N., Boddicker, R. L., Hu, G., Benson, H. K., Ketterling, R. P., Greipp, P. T., Knutson, D. L., Kloft-Nelson, S. M., He, R., Eckloff, B. W., Jen, J., Nair, A. A., Davila, J. I., Dasari, S., Lazaridis, K. N., Nora Bennani, N., Wu, T. T., Nowakowski, G. S., Murray, J. A. & 1 others, Feldman, A. L., May 17 2018, In : Blood. 131, 20, p. 2262-2262-2266

Research output: Contribution to journalLetter

17 Scopus citations

T cell/histiocyte-rich large B cell lymphoma: Incidence, demographic disparities, and long-term outcomes

Kommalapati, A., Tella, S. H., Go, R. S., Nowakowski, G. S. & Goyal, G., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

3 Scopus citations

The diagnosis and treatment of primary vitreoretinal lymphoma: A review

Pulido, J. S., Johnston, P. B., Nowakowski, G. S., Castellino, A. & Raja, H., Jan 1 2018, In : International Journal of Retina and Vitreous. 4, 1, 18.

Research output: Contribution to journalReview article

12 Scopus citations

Treatment strategies, outcomes and prognostic factors in 291 patients with secondary CNS involvement by diffuse large B-cell lymphoma

El-Galaly, T. C., Cheah, C. Y., Bendtsen, M. D., Nowakowski, G. S., Kansara, R., Savage, K. J., Connors, J. M., Sehn, L. H., Goldschmidt, N., Shaulov, A., Farooq, U., Link, B. K., Ferreri, A. J. M., Calimeri, T., Cecchetti, C., Dann, E. J., Thompson, C. A., Inbar, T., Maurer, M. J., Gade, I. L. & 14 others, Juul, M. B., Hansen, J. W., Holmberg, S., Larsen, T. S., Cordua, S., Mikhaeel, N. G., Hutchings, M., Seymour, J. F., Clausen, M. R., Smith, D., Opat, S., Gilbertson, M., Thanarajasingam, G. & Villa, D., Apr 2018, In : European Journal of Cancer. 93, p. 57-68 12 p.

Research output: Contribution to journalArticle

14 Scopus citations
2017

A phase 2 study of lenalidomide, rituximab, cyclophosphamide, and dexamethasone (LR-CD) for untreated low-grade non-Hodgkin lymphoma requiring therapy

Rosenthal, A., Dueck, A., Ansell, S. M., Gano, K., Conley, C., Nowakowski, G. S., Camoriano, J. K., Leis, J. F., Mikhael, J. R., Stewart, A. K., Inwards, D., Dingli, D. M., Kumar, S. K., Noel, P., Gertz, M., Porrata, L., Russell, S. J., Colgan, J., Fonseca, R., Habermann, T. M. & 6 others, Kapoor, P., Buadi, F., Leung, N., Tiedemann, R., Witzig, T. E. & Reeder, C., May 1 2017, In : American Journal of Hematology. 92, 5, p. 467-472 6 p.

Research output: Contribution to journalArticle

5 Scopus citations

Clinical heterogeneity of diffuse large B cell lymphoma following failure of front-line immunochemotherapy

Farooq, U., Maurer, M. J., Thompson, C. A., Thanarajasingam, G., Inwards, D. J., Micallef, I., Macon, W., Syrbu, S., Lin, T., Lin, Y., Ansell, S. M., Nowakowski, G. S., Habermann, T. M., Cerhan, J. R. & Link, B. K., Oct 1 2017, In : British Journal of Haematology. 179, 1, p. 50-60 11 p.

Research output: Contribution to journalArticle

19 Scopus citations

Cohort profile: The lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) cohort study

Cerhan, J. R., Link, B. K., Habermann, T. M., Maurer, M. J., Feldman, A. L., Syrbu, S. I., Thompson, C. A., Farooq, U., Novak, A. J., Slager, S. L., Allmer, C., Lunde, J. J., Macon, W. R., Inwards, D. J., Johnston, P. B., Micallef, I. N. M., Nowakowski, G. S., Ansell, S. M., Kay, N. E., Weiner, G. J. & 1 others, Witzig, T. E., Dec 1 2017, In : International journal of epidemiology. 46, 6, p. 1753-1754 and 1754a-1754i

Research output: Contribution to journalArticle

19 Scopus citations
53 Scopus citations

Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma

Bennani, N., LaPlant, B. R., Ansell, S. M., Habermann, T. M., Inwards, D. J., Micallef, I., Johnston, P. B., Porrata, L. F., Colgan, J. P., Markovic, S. N., Nowakowski, G. S., Macon, W. R., Reeder, C. B., Mikhael, J. R., Northfelt, D. W., Ghobrial, I. M. & Witzig, T. E., May 1 2017, In : American Journal of Hematology. 92, 5, p. 448-453 6 p.

Research output: Contribution to journalArticle

13 Scopus citations

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

Bryce, A. H., Egan, J. B., Borad, M. J., Keith Stewart, A., Nowakowski, G. S., Chanan-Khan, A., Patnaik, M. M., Ansell, S. M., Banck, M. S., Robinson, S. I., Mansfield, A. S., Klee, E. W., Oliver, G. R., McCormick, J. B., Huneke, N. E., Tagtow, C. M., Jenkins, R. B., Rumilla, K. M., Kerr, S. E., Kocher, J. P. A. & 5 others, Beck, S. A., Fernandez-Zapico, M. E., Farrugia, G., Lazaridis, K. N. & McWilliams, R. R., 2017, In : Oncotarget. 8, 16, p. 27145-27154 10 p.

Research output: Contribution to journalArticle

20 Scopus citations

Frequency, risk factors, and outcomes of central nervous system relapse in lymphoma patients treated with dose-adjusted EPOCH plus rituximab

Malecek, M. K., Petrich, A. M., Rozell, S., Chu, B., Trifilio, S., Galanina, N., Maurer, M., Farooq, U., Link, B. K., Nowakowski, G. S., Nabhan, C. & Ayed, A. O., 2017, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

4 Scopus citations

Molecular modeling and functional analysis of exome sequencing-derived variants of unknown significance identify a novel, constitutively active FGFR2 mutant in cholangiocarcinoma

Egan, J. B., Marks, D. L., Hogenson, T. L., Vrabel, A. M., Sigafoos, A. N., Tolosa, E. J., Carr, R. M., Safgren, S. L., Hesles, E. E., Almada, L. L., Romecin-Duran, P. A., Iguchi, E., Ala'Aldeen, A., Kocher, J. P. A., Oliver, G. R., Prodduturi, N., Mead, D. W., Hossain, A., Huneke, N. E., Tagtow, C. M. & 43 others, Ailawadhi, S., Ansell, S. M., Banck, M. S., Bryce, A. H., Carballido, E. M., Chanan-Khan, A. A., Curtis, K. K., Resnik, E., Gawryletz, C. D., Go, R. S., Halfdanarson, T. R., Ho, T. H., Joseph, R. W., Kapoor, P., Mansfield, A. S., Meurice, N., Rao, A. A. N., Nowakowski, G. S., Pardanani, A., Parikh, S. A., Cheville, J. C., Feldman, A. L., Ramanathan, R. K., Robinson, S. I., Tibes, R., Finnes, H. D., McCormick, J. B., McWilliams, R. R., Jatoi, A., Patnaik, M. M., Silva, A. C., Wieben, E. D., McAllister, T. M., Rumilla, K. M., Kerr, S. E., Lazaridis, K. N., Farrugia, G., Keith Stewart, A., Clark, K. J., Kennedy, E. J., Klee, E. W., Borad, M. J. & Fernandez-Zapico, M. E., Jan 1 2017, In : JCO Precision Oncology. 2017, 1, p. 1-13 13 p.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W., LaPlant, B. R., Call, T. G., Parikh, S. A., Leis, J. F., He, R., Shanafelt, T. D., Sinha, S., Le-Rademacher, J., Feldman, A. L., Habermann, T. M., Witzig, T. E., Wiseman, G. A., Lin, Y., Asmus, E., Nowakowski, G. S., Conte, M. J., Bowen, D. A., Aitken, C. N., Van Dyke, D. L. & 15 others, Greipp, P. T., Liu, X., Wu, X., Zhang, H., Secreto, C. R., Tian, S., Braggio, E., Wellik, L. E., Micallef, I., Viswanatha, D. S., Yan, H., Chanan-Khan, A. A., Kay, N. E., Dong, H. & Ansell, S. M., Jun 29 2017, In : Blood. 129, 26, p. 3419-3427 9 p.

Research output: Contribution to journalArticle

130 Scopus citations